We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$7.48B
1-Year Est. Return
104.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.88%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$5.45B
AUM Growth
+$379M
(+7.5%)
Cap. Flow
+$62.7M
Cap. Flow
% of AUM
1.15%
Top 10 Holdings %
Top 10 Hldgs %
26.99%
Holding
161
New
18
Increased
65
Reduced
42
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Doximity
DOCS
|
+$43.7M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$39.4M |
| 3 |
Lithia Motors
LAD
|
+$30.5M |
| 4 |
Palo Alto Networks
PANW
|
+$25.7M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTM
ZoomInfo Technologies
GTM
|
+$82.3M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$41.8M |
| 3 |
Immunovant
IMVT
|
+$40M |
| 4 |
DoubleVerify
DV
|
+$35.4M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$34.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.48% |
| 2 | Technology | 23.47% |
| 3 | Industrials | 13.06% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Utilities | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Royalty Pharma
RPRX
$26B
| $37.8M | 0.69% |
1,049,113
+300,690
| +40% | +$11.1M |
|
52
Datadog
DDOG
$82.7B
| $36M | 0.66% |
495,232
-10,694
| -2% | -$785K |
|
53
Enphase Energy
ENPH
$4.85B
| $36M | 0.66% |
171,081
+1,000
| +0.6% | +$217K |
|
54
nVent Electric
NVT
$23.8B
| $34.5M | 0.63% |
802,503
-42,553
| -5% | -$1.79M |
|
|
KDNY
55
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $33.3M | 0.61% |
1,439,564
+1,070,753
| +290% | +$25.5M |
|
56
CDW
CDW
$19.2B
| $33.1M | 0.61% |
169,795
+14,628
| +9% | +$2.87M |
|
|
APLS
57
DELISTED
Apellis Pharmaceuticals
APLS
| $32.7M | 0.6% |
495,000
+155,645
| +46% | +$8.98M |
|
|
NARI
58
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $31.7M | 0.58% |
512,914
+163,203
| +47% | +$9.79M |
|
|
VECT
59
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $31.6M | 0.58% |
3,675,644
+270,000
| +8% | +$2.23M |
|
60
Crown Castle
CCI
$31.2B
| $31.5M | 0.58% |
235,052
-122,274
| -34% | -$16.9M |
|
61
Synopsys
SNPS
$70.5B
| $30.8M | 0.56% |
79,712
+15,341
| +24% | +$5.48M |
|
62
iRhythm Holdings
IRTC
$3.69B
| $29.7M | 0.54% |
239,135
| – | – |
|
|
63
Lithia Motors
LAD
$7.6B
| $28.7M | 0.53% |
+125,499
| New | +$30.5M |
|
64
Cogent Biosciences
COGT
$5.68B
| $27.9M | 0.51% |
2,589,778
| – | – |
|
65
Privia Health
PRVA
$2.6B
| $27.6M | 0.51% |
1,000,000
| – | – |
|
66
Prologis
PLD
$129B
| $27.2M | 0.5% |
218,216
+157,750
| +261% | +$19.4M |
|
67
Brookfield Renewable
BEPC
$5.39B
| $27.1M | 0.5% |
775,403
+384
| +0% | +$11.6K |
|
68
Steris
STE
$20.5B
| $26.1M | 0.48% |
136,516
-2,929
| -2% | -$566K |
|
69
O'Reilly Automotive
ORLY
$68.9B
| $25.8M | 0.47% |
456,360
+453,540
| +16,083% | +$24.8M |
|
70
Sarepta Therapeutics
SRPT
$2.19B
| $25.8M | 0.47% |
+187,268
| New | +$24.3M |
|
71
Inspire Medical Systems
INSP
$2.16B
| $25.3M | 0.46% |
108,220
| – | – |
|
72
Aura Biosciences
AURA
$718M
| $23.4M | 0.43% |
2,525,830
+274,462
| +12% | +$2.85M |
|
73
Xenon Pharmaceuticals
XENE
$5.45B
| $22.9M | 0.42% |
641,200
| – | – |
|
74
Arthur J. Gallagher & Co
AJG
$63.6B
| $22.9M | 0.42% |
119,758
+27,676
| +30% | +$5.25M |
|
75
Targa Resources
TRGP
$61.3B
| $22.8M | 0.42% |
312,949
+173,388
| +124% | +$12.8M |
|
Similar funds
S
CCM
O
HI
HPC
FPP
RIG
TAM
Eventide Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Eventide Asset Management held 161 positions worth $5.45B, up 7.5% from $5.07B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Eventide Asset Management's Q1 2023 filing shows 18 new, 65 increased, 42 reduced and 14 closed positions. Its largest new stake was Lithia Motors: 125,499 shares worth $28.7M. The largest sale was ZoomInfo Technologies, an estimated $82.3M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.
- Eventide Asset Management's largest Q1 2023 buy was Lithia Motors: 125,499 shares worth $28.7M.
- Eventide Asset Management added most to Doximity in Q1 2023, an estimated $43.7M increase.
- Eventide Asset Management's biggest Q1 2023 reduction was ZoomInfo Technologies, cutting an estimated $82.3M.
- Eventide Asset Management fully exited Bicycle Therapeutics in Q1 2023, selling an estimated $25.3M.
- Eventide Asset Management's ten largest holdings make up 27% of its $5.45B portfolio in Q1 2023.
- Eventide Asset Management opened 18 new positions and closed 14 in Q1 2023.
- Eventide Asset Management's portfolio value rose 7.5% quarter-over-quarter to $5.45B.
Based on Eventide Asset Management's 13F filing for Q1 2023, filed 15 May 2023.